ArticleHuman vaccines & immunotherapeutics2021

Reply letter regarding seroconversion of hepatitis B surface antigen in a successful long-term immune cohort.

Zhigang Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.